AERI
Aerie Pharmaceuticals
AERI
AERI
Delisted
AERI was delisted on the 18th of November, 2022.
176 hedge funds and large institutions have $2.26B invested in Aerie Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 37 funds opening new positions, 69 increasing their positions, 46 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
23% more call options, than puts
Call options by funds: $6.61M | Put options by funds: $5.39M
10% more funds holding
Funds holding: 160 → 176 (+16)
Holders
176
Holding in Top 10
10
Calls
$6.61M
Puts
$5.39M
Top Buyers
| 1 | +$80.6M | |
| 2 | +$22.5M | |
| 3 | +$16.8M | |
| 4 |
DCM
Daruma Capital Management
New York
|
+$13.4M |
| 5 |
GIP
Granite Investment Partners
El Segundo,
California
|
+$13.3M |
Top Sellers
| 1 | -$68.4M | |
| 2 | -$55.9M | |
| 3 | -$42.3M | |
| 4 |
O
OrbiMed
New York
|
-$38.7M |
| 5 |
CCI
Columbus Circle Investors
|
-$21.6M |